<transcript><audio_46> Это и другие признаки сексуального нарушения и так дальше. Так вот, пациенты низкого риска не подлежат такой гормонотерапии. Здесь можно ограничиться обычной гормонотерапией.</transcript><transcript><audio_47> А вот у пациента высокого риска по этой классификации, там действительно есть преимущество одновременного назначения гормонального препарата, ингибитора ароматаза.</transcript><transcript><audio_48> НГДПП</transcript><transcript><audio_49> женщины с промежуточным риском и отсутствует практически для женщин низкого риска. Но это мы говорили о ранних</transcript> means in postmenopause for part of the question this and other signs of sexual expression so on and so low- risk patients are not subject to such a trapt hormone here you can limit yourself to the usual tara hormone in this October for us but for high-risk patients according to this classification there really is an advantage of simultaneous  prescribing a hormonal drug is not a bit of aromatase menopause places on ordinary people from the collapse and in the press of suppression of a couple of envy to for five years they 2 goes as before and for five years and well, in general, and the potential benefits of escalation of the year it is minimal for women and form  and all the risks are practically for low-risk women, but we were talking about the early stages of
{"source": "grass-yt-cc-by.1BgMHS5JEQA|shard_10012_18|create_multimodal_data.extract_yt_and_generate_transcripts.54|shard_10012|create_multimodal_data.generate_captions.65|shard_10012|create_multimodal_data.generate_captions.57", "params": {"id": "1BgMHS5JEQA", "channel_id": "UC5MS3dmfVp-htSABu6j4oLQ", "duration": 1709, "view_count": 971, "age_limit": 0, "like_count": 28, "channel_follower_count": 61800, "license": "Creative Commons Attribution license (reuse allowed)", "uploader_id": "@Niioncologii", "yt_tar_file": "/leonardo_work/EUHPC_E03_068/audio/fixed_download/grass-yt-cc-by//shard_10012/1BgMHS5JEQA.tar.gz"}}